No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Dasatinib / therapeutic use*
-
Humans
-
Leukemia, Myeloid, Chronic-Phase / drug therapy*
-
Prognosis
-
Protein Kinase Inhibitors
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Dasatinib